Blood cyclosporine C0 and C2 concentrations and cytomegalovirus infections following lung transplantation

被引:6
作者
Monforte, V
Bullich, S
Pou, L
Bravo, C
López, R
Gavaldà, J
Roman, A
机构
[1] Hosp Gen Valle Hebron, Dept Pneumol, Barcelona, Spain
[2] Hosp Gen Valle Hebron, Clin Lab Unit, Barcelona, Spain
[3] Hosp Gen Valle Hebron, Dept Infect Dis, Barcelona, Spain
关键词
D O I
10.1016/S0041-1345(03)00689-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this study was to determine whether cyclosporine levels predose (C-0) and at two hours postdose (C-2) were higher among patients presenting with cytomegalovirus (CMV) infection or disease. Between days 40 and 365 posttransplantation serial C-0 and C-2 levels were measured in 15 lung transplant recipients. Nine developed 13 episodes of CMV infection or disease. Both C-0 and C-2 levels were higher during CMV infection or disease episodes. Eleven of the 13 CMV episodes (84%) displayed C-0 > 220 ng/mL and none had C-0 < 200 ng/mL. For C-2, 11 of 13 CMV episodes (84%) showed C-2 > 1200 ng/mL and none had C-2 < 1000 ng/mL. Among determinations that did not coincide with a CMV episode, 7 of 21 (33%) showed C-0 > 220 and 9 of 21 (42%) showed C-2 > 1200, respectively (P < .05). In conclusion, cyclosporine blood levels are higher among patients presenting with CMV infection or disease.
引用
收藏
页码:1992 / 1993
页数:2
相关论文
共 6 条
[1]   Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient [J].
Alain, S ;
Honderlick, P ;
Grenet, D ;
Stern, M ;
Vadam, C ;
SansonLePors, MJ ;
Mazeron, MC .
TRANSPLANTATION, 1997, 63 (10) :1533-1536
[2]   BLOOD CYCLOSPORINE CONCENTRATIONS AND CYTOMEGALOVIRUS-INFECTION FOLLOWING HEART-TRANSPLANTATION [J].
BEST, NG ;
TRULL, AK ;
TAN, KKC ;
SPIEGELHALTER, DJ ;
WREGHITT, TG ;
WALLWORK, J .
TRANSPLANTATION, 1995, 60 (07) :689-694
[3]  
COSTANZONORDIN MR, 1992, J HEART LUNG TRANSPL, V11, P837
[4]   Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation [J].
Muñoz, MA ;
Andrés, A ;
Gallego, R ;
Morales, E ;
Morales, JM ;
Aguado, JM ;
Lumbreras, C ;
Torres, A ;
Rodicio, JL ;
Praga, M .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) :97-97
[5]   Clinical validation studies of Neoral C2 monitoring:: A review [J].
Nashan, B ;
Cole, E ;
Levy, G ;
Thervet, E .
TRANSPLANTATION, 2002, 73 (09) :S3-S11
[6]   Controversies in lung transplantation: Management of cytomegalovirus infections [J].
Zamora, MR .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (08) :841-849